CervoMed (CRVO) EPS (Basic) (2022 - 2025)
CervoMed's EPS (Basic) history spans 9 years, with the latest figure at -$0.84 for Q3 2025.
- For Q3 2025, EPS (Basic) fell 52.73% year-over-year to -$0.84; the TTM value through Sep 2025 reached -$2.89, down 32.57%, while the annual FY2024 figure was -$2.02, 146.34% down from the prior year.
- EPS (Basic) for Q3 2025 was -$0.84 at CervoMed, down from -$0.7 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.91 in Q3 2023 and bottomed at -$6.93 in Q4 2022.
- The 4-year median for EPS (Basic) is -$0.84 (2025), against an average of -$1.19.
- The largest annual shift saw EPS (Basic) skyrocketed 330.0% in 2023 before it tumbled 159.26% in 2025.
- A 4-year view of EPS (Basic) shows it stood at -$6.93 in 2022, then surged by 86.29% to -$0.95 in 2023, then increased by 16.84% to -$0.79 in 2024, then decreased by 6.33% to -$0.84 in 2025.
- Per Business Quant, the three most recent readings for CRVO's EPS (Basic) are -$0.84 (Q3 2025), -$0.7 (Q2 2025), and -$0.56 (Q1 2025).